In PAAD, high expression of SP100, SP110, SP140, and SP140L consistently correlated with poor prognosis (Yunjie Duan, 2023), in contrast with another study linking SP110 to better outcomes. Here, SP140L is linked to pancreatic adenocarcinoma.